---
title: Sex differences and clinical outcomes, including ventricular tachyarrhythmias,
  of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
date: '2025-01-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39749312/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250103170653&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Women with HFrEF treated with sacubitril/valsartan showed
  a greater improvement in LVEF compared to men, though clinical outcomes were similar
  across sexes. Female sex was not a predictor of ventricular tachyarrhythmias or
  mortality at 12 ...'
disable_comments: true
---
CONCLUSION: Women with HFrEF treated with sacubitril/valsartan showed a greater improvement in LVEF compared to men, though clinical outcomes were similar across sexes. Female sex was not a predictor of ventricular tachyarrhythmias or mortality at 12 ...